← Open Payments lookup

LADONNA SCHMIDT: Open Payments

NPI 1205857018 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,110 in 56 payments from 16 companies in 2025. Trend: 2023 $1,394 · 2024 $883 · 2025 $1,110

Food & beverage: $1,110
CompanyPaymentsAmount
ABBVIE INC.20$345
Janssen Biotech, Inc.8$173
Lilly USA, LLC4$85
Takeda Pharmaceuticals U.S.A., Inc.3$80
GENZYME CORPORATION3$80
Gilead Sciences, Inc.3$61
Intercept Pharmaceuticals, Inc.3$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$47
QOL Medical, LLC2$31
Phathom Pharmaceuticals, Inc.2$30

Products named: RINVOQ, TREMFYA, DUPIXENT, OMVOH, OCALIVA, XIFAXAN, MAVYRET, SKYRIZI.

Industry payments across IN — which companies pay providers there.